These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 36797553)

  • 1. The role of gut-dependent molecule trimethylamine N-oxide as a novel target for the treatment of chronic kidney disease.
    Pan S; Zhao D; Duan S; Chen X
    Int Urol Nephrol; 2023 Jul; 55(7):1747-1756. PubMed ID: 36797553
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeted Inhibition of Gut Microbial Trimethylamine N-Oxide Production Reduces Renal Tubulointerstitial Fibrosis and Functional Impairment in a Murine Model of Chronic Kidney Disease.
    Gupta N; Buffa JA; Roberts AB; Sangwan N; Skye SM; Li L; Ho KJ; Varga J; DiDonato JA; Tang WHW; Hazen SL
    Arterioscler Thromb Vasc Biol; 2020 May; 40(5):1239-1255. PubMed ID: 32212854
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Trimethylamine-N-oxide and cardiovascular events in chronic kidney disease].
    Dai Q; Zhang H; Liu Y
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2019 Nov; 44(11):1294-1299. PubMed ID: 31919326
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elevation of Trimethylamine-N-Oxide in Chronic Kidney Disease: Contribution of Decreased Glomerular Filtration Rate.
    Pelletier CC; Croyal M; Ene L; Aguesse A; Billon-Crossouard S; Krempf M; Lemoine S; Guebre-Egziabher F; Juillard L; Soulage CO
    Toxins (Basel); 2019 Nov; 11(11):. PubMed ID: 31683880
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trimethylamine-N-Oxide Aggravates Kidney Injury via Activation of p38/MAPK Signaling and Upregulation of HuR.
    Lai Y; Tang H; Zhang X; Zhou Z; Zhou M; Hu Z; Zhu F; Zhang L; Nie J
    Kidney Blood Press Res; 2022; 47(1):61-71. PubMed ID: 34788763
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gut microbiota-dependent trimethylamine N-oxide (TMAO) pathway contributes to both development of renal insufficiency and mortality risk in chronic kidney disease.
    Tang WH; Wang Z; Kennedy DJ; Wu Y; Buffa JA; Agatisa-Boyle B; Li XS; Levison BS; Hazen SL
    Circ Res; 2015 Jan; 116(3):448-55. PubMed ID: 25599331
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rapid Detection of Gut Microbial Metabolite Trimethylamine N-Oxide for Chronic Kidney Disease Prevention.
    Chang YC; Chu YH; Wang CC; Wang CH; Tain YL; Yang HW
    Biosensors (Basel); 2021 Sep; 11(9):. PubMed ID: 34562929
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trimethylamine N-Oxide: The Good, the Bad and the Unknown.
    Velasquez MT; Ramezani A; Manal A; Raj DS
    Toxins (Basel); 2016 Nov; 8(11):. PubMed ID: 27834801
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of microbiota-dependent TMAO production attenuates chronic kidney disease in mice.
    Zhang W; Miikeda A; Zuckerman J; Jia X; Charugundla S; Zhou Z; Kaczor-Urbanowicz KE; Magyar C; Guo F; Wang Z; Pellegrini M; Hazen SL; Nicholas SB; Lusis AJ; Shih DM
    Sci Rep; 2021 Jan; 11(1):518. PubMed ID: 33436815
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The guanylate cyclase C agonist linaclotide ameliorates the gut-cardio-renal axis in an adenine-induced mouse model of chronic kidney disease.
    Nanto-Hara F; Kanemitsu Y; Fukuda S; Kikuchi K; Asaji K; Saigusa D; Iwasaki T; Ho HJ; Mishima E; Suzuki T; Suzuki C; Tsukimi T; Matsuhashi T; Oikawa Y; Akiyama Y; Kure S; Owada Y; Tomioka Y; Soga T; Ito S; Abe T
    Nephrol Dial Transplant; 2020 Feb; 35(2):250-264. PubMed ID: 31411705
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gut microbiota-derived trimethylamine N-oxide is associated with the risk of all-cause and cardiovascular mortality in patients with chronic kidney disease: a systematic review and dose-response meta-analysis.
    Li Y; Lu H; Guo J; Zhang M; Zheng H; Liu Y; Liu W
    Ann Med; 2023 Dec; 55(1):2215542. PubMed ID: 37246850
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gut microbial metabolite TMAO contributes to renal dysfunction in a mouse model of diet-induced obesity.
    Sun G; Yin Z; Liu N; Bian X; Yu R; Su X; Zhang B; Wang Y
    Biochem Biophys Res Commun; 2017 Nov; 493(2):964-970. PubMed ID: 28942145
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effect of traditional Chinese medicine in attenuating chronic kidney disease and its complications by regulating gut microbiota-derived metabolite trimethylamine N-oxide: a review].
    Yong C; Huang GS; Ge HW; Sun QM; Gao K; Zhou EC
    Zhongguo Zhong Yao Za Zhi; 2023 Jan; 48(2):321-328. PubMed ID: 36725221
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trimethylamine N-Oxide, the Microbiome, and Heart and Kidney Disease.
    Zeisel SH; Warrier M
    Annu Rev Nutr; 2017 Aug; 37():157-181. PubMed ID: 28715991
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impaired renal function and dysbiosis of gut microbiota contribute to increased trimethylamine-N-oxide in chronic kidney disease patients.
    Xu KY; Xia GH; Lu JQ; Chen MX; Zhen X; Wang S; You C; Nie J; Zhou HW; Yin J
    Sci Rep; 2017 May; 7(1):1445. PubMed ID: 28469156
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibiotic-induced intestinal microbiota depletion can attenuate the acute kidney injury to chronic kidney disease transition via NADPH oxidase 2 and trimethylamine-N-oxide inhibition.
    Lee J; Lee J; Kim K; Lee J; Jung Y; Hyeon JS; Seo A; Jin W; Weon B; Shin N; Kim S; Lim CS; Kim YS; Lee JP; Hwang GS; Yang SH
    Kidney Int; 2024 Jun; 105(6):1239-1253. PubMed ID: 38431216
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    Wang Q; Guo M; Liu Y; Xu M; Shi L; Li X; Zhao J; Zhang H; Wang G; Chen W
    Nutrients; 2022 Mar; 14(6):. PubMed ID: 35334879
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plant-Based Diets, the Gut Microbiota, and Trimethylamine N-Oxide Production in Chronic Kidney Disease: Therapeutic Potential and Methodological Considerations.
    Wiese GN; Biruete A; Moorthi RN; Moe SM; Lindemann SR; Hill Gallant KM
    J Ren Nutr; 2021 Mar; 31(2):121-131. PubMed ID: 32616440
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of trimethylamine N-oxide as a mediator of cardiovascular complications in chronic kidney disease.
    Tomlinson JAP; Wheeler DC
    Kidney Int; 2017 Oct; 92(4):809-815. PubMed ID: 28807612
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trimethylamine N-oxide promotes hyperoxaluria-induced calcium oxalate deposition and kidney injury by activating autophagy.
    Dong F; Jiang S; Tang C; Wang X; Ren X; Wei Q; Tian J; Hu W; Guo J; Fu X; Liu L; Patzak A; Persson PB; Gao F; Lai EY; Zhao L
    Free Radic Biol Med; 2022 Feb; 179():288-300. PubMed ID: 34767921
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.